PF2

2-(4-{(3S,5S)-5-[(3,3-difluoropyrrolidin-1-yl)carbonyl]pyrrolidin-3-yl}piperazin-1-yl)pyrimidine

Find entries where: PF2

is present as a standalone ligand in 1 entries

Find related ligands:

Chemical Component Summary
Name	2-(4-{(3S,5S)-5-[(3,3-difluoropyrrolidin-1-yl)carbonyl]pyrrolidin-3-yl}piperazin-1-yl)pyrimidine
Identifiers	(3,3-difluoropyrrolidin-1-yl)-[(2S,4S)-4-(4-pyrimidin-2-ylpiperazin-1-yl)pyrrolidin-2-yl]methanone
Formula	C₁₇ H₂₄ F₂ N₆ O
Molecular Weight	366.409
Type	NON-POLYMER
Isomeric SMILES	c1cnc(nc1)N2CCN(CC2)[C@H]3C[C@H](NC3)C(=O)N4CCC(C4)(F)F
InChI	InChI=1S/C17H24F2N6O/c18-17(19)2-5-25(12-17)15(26)14-10-13(11-22-14)23-6-8-24(9-7-23)16-20-3-1-4-21-16/h1,3-4,13-14,22H,2,5-12H2/t13-,14-/m0/s1
InChIKey	QWEWGXUTRTXFRF-KBPBESRZSA-N

Chemical Details
Formal Charge	0
Atom Count	50
Chiral Atom Count	2
Bond Count	53
Aromatic Bond Count	6

Drug Info: DrugBank

DrugBank ID	DB08382
Name	Gosogliptin
Groups	investigational
Description	Gosogliptin has been used in trials studying the treatment of Renal Insufficiency, Chronic.
Synonyms	2-(4-{(3S,5S)-5-[(3,3-difluoropyrrolidin-1-yl)carbonyl]pyrrolidin-3-yl}piperazin-1-yl)pyrimidine Gosogliptin
Categories	Agents causing angioedema Blood Glucose Lowering Agents Diabetes Mellitus, Type 2, drug therapy DPP-IV Inhibitors
CAS number	869490-23-3

Drug Targets

Name	Target Sequence	Pharmacological Action	Actions
Dipeptidyl peptidase 4	MKTPWKVLLGLLGAAALVTIITVPVVLLNKGTDDATADSRKTYTLTDYLK...	unknown

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682